Clinical Trials Logo
  1. Home
  2. Renal Failure, Chronic
  3. NCT05077163
  4. Details
NCT05077163 Clinical Trial

Patients With Acute Renal Failure During Severe COVID-19

Renal Failure Chronic Clinical Trial

— IR-EST-POSTCOV  

Official title:
Renal Assessment of Patients With Acute Renal Failure During Severe COVID-19

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05077163
Other study ID # 8039
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 1, 2020
Est. completion date December 2021

Study information
Verified date October 2021
Source University Hospital, Strasbourg, France
Contact Bruno MOULIN, MD, PhD
Phone 33 3 69 55 05 11
Email Bruno.Moulin@chru-strasbourg.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The occurrence of renal failure during severe forms of COVID-19 is common (20-35% of patients treated in intensive care) and associated with an unfavorable short-term prognosis, but the medium-term renal outcome is not is not known. The aim of the study is to establish the frequency of chronic kidney failure after AKI KDIGO 2 and 3 occurring during severe COVID-19 in intensive care.

Recruitment information / eligibility
Status Recruiting
Enrollment 40
Est. completion date December 2021
Est. primary completion date December 2021
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: - Major subject (=18 years old) - Subject hospitalized in an intensive care unit, Strasbourg, Nancy or Reims hospitals, for severe COVID-19 between February 1, 2020 and July 31, 2020. - Having presented acute renal failure KDIGO 2 (assessed on a doubling of serum creatinine compared to the patient's reference values) or 3 (serum creatinine greater than 3 times the patient's reference, or anuria, or any recourse to extra-purification renal) - Having left hospital alive after initial treatment for COVID-19 - Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research. Exclusion criteria: - Subject having expressed opposition to participating in the study - Subject under guardianship or guardianship - Subject under safeguard of justice

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France Service de Néphrologie et Transplantation - Hôpitaux Universitaires de Strasbourg Strasbourg

Sponsors (1)
Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Retrospective study of renal development in patients with acute renal failure during severe COVID-19 Files analysed retrospectively from February 01, 2020 to July 31, 2020 will be examined]
See also
  Status Clinical Trial Phase
Completed NCT03246984 - VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ N/A
Completed NCT05787080 - Massage, Oxidative and Antioxidant Enzymes in Hemodialysis Patients With Restless Legs Syndrome(RLS) N/A
Completed NCT05585268 - Electronic Decision Support for Deprescribing in Patients on Hemodialysis N/A
Completed NCT02332811 - An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients Phase 3
Withdrawn NCT03093740 - Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant Phase 4
Recruiting NCT04908345 - Methadone Anesthesia For Kidney Transplant Receptors Phase 3
Completed NCT05769686 - Laparoscopic Donor Nephrectomy Score, a New Scoring System for Preoperative Prediction of Difficulty of Laparoscopic Donor Nephrectomy
Completed NCT03949036 - Comparison of Two Different Preload Targets of Stroke Volume Variation During Kidney Transplantation N/A
Completed NCT04204005 - Probiotics and Low Protein Diet in Advanced Chronic Kidney Disease N/A
Completed NCT03658876 - Predictors of Response to Iron and Erythropoietin Stimulating Agents Phase 4
Not yet recruiting NCT04377243 - Immunotherapy of Chronic Kidney Failure Phase 2
Active, not recruiting NCT05418816 - SelfWrap-Assisted Arteriovenous Fistulas N/A
Active, not recruiting NCT03436368 - Continuous Spinal Anesthesia in Renal Transplantation N/A
Recruiting NCT03778944 - Enhancing Renal Graft Function During Donor Anesthesia N/A
Recruiting NCT05521425 - Randomized Controlled Trial on 3D Printed Assistive Device for Continuous Ambulatory Peritoneal Dialysis N/A
Active, not recruiting NCT05381961 - Observational Study of BIS in Hemodialysis Patients
Completed NCT03781726 - Multi-center Study to Transplant Hepatitis-C Infected Kidneys Phase 4